Physicians will now be able to send medication directly to the needed area with the new IsoFlow Lateral Infusion Catheter by Vascular Designs.
Isoflow uses sideway perfusion technology to enable chemotherapy agents to reach the areas that other devices cannot directly target. Because it can directly target cancer cells instead of “saturation bombing” the entire body with therapeutic agents, the Isolow catheter is a promising device for cancer treatment.
The catheter uses a guidewire to enter the body and come in direct contact with an area, isolating it from its surrounding, giving confidence that the treatment will go directly to where it is needed. According to Vascular Designs, “This approach lets physicians increase drug concentrations at targeted sites while reducing systemic exposure, thereby improving efficacy and patient outcomes when treating illnesses such as cancer with chemotherapy.”
Then, the dual-balloon catheter is placed over the wire to directly target. Once inside, the balloons inflate in unison and the guidewire is then pulled back and then the infusion syringe pushes out a high concentration of treatment through the catheter tube and then to the targeted area.
“IsoFlow could have a huge impact on the way many of today’s deadliest illnesses such as cancer are treated. This method of local delivery may cause tumors that were previously unresponsive to systemic chemotherapy to respond. Additionally, the IsoFlow catheter may be able to provide treatment for a number of other medical conditions for which local delivery would be an ideal option,” said CEO and founder Robert Goldman. “The potential applications of IsoFlow are exciting. We are looking forward to seeing how physicians will leverage this breakthrough catheter medical device into practice and the impact that it will surely make on the prognosis of so many patients.”
In an effort to help expand IsoFlow’s availability, Vascular Designs will be launching a campaign on Monday, October 17th and will last for 30 days with the goal of $500,000. A portion of the money raised will go towards the expansion of treatment locations and providing physicians with additional options.
“This global effort will help put the IsoFlow in the hands of as many physicians as possible,” said Goldman. “Crowdfunding through Indiegogo lets individuals world-wide participate in this global effort to help others in their fight against cancer.”
To join the campaign go to, https://www.indiegogo.com/at/cancer-killer.